SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Nov 28 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Scott Pratho who wrote (948)12/24/1997 2:59:00 AM
From: Mr. Pink  Read Replies (2) of 1359
 
To anybody:

Isn't anyone nervous about the possibility that IPIC could get sued into bankruptcy by former users of dex-fenfluramine, if enough of said users can prove in court that said drug caused damage to their heart-valves?

Additionally, anyone read the research by a team at Johns Hopkins done about a couple of years ago that demonstrated brain damage in monkeys dosed with dex-fenfluramine?

I may be mistaken on item #1, since I don't know whether it's the phentermine or the fenfluramine part of phen/fen which is implicated in the heart-valve damage.

Thanks for your advisement.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News